Data as of Jan 30
| +0.02 / +0.85%|
The 6 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 5.50 and a low estimate of 1.50. The median estimate represents a +48.31% increase from the last price of 2.36.
The current consensus among 8 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.